President Trump to sign an executive order on Monday to drastically reduce prescription drug prices, potentially lowering costs by 30% to 80%. His announcement highlights long-standing issues of price discrepancies in the U.S. compared to global markets. The order aims to implement a “Most Favored Nation’s Policy” to ensure fair pricing for Americans and eliminate pharmaceutical corruption, promising significant savings for the country.
In a bold move that could reshape the landscape of pharmaceutical pricing, President Donald Trump has announced an executive order poised to slash prescription drug costs by an astounding 30% to 80%. He made this announcement via Truth Social on Sunday, stirring up conversation about the long-standing high prices in the U.S. market.
During his statement, Trump took a moment to reflect on the perplexing question: why are American drug prices so much higher than in other countries? He noted, often they can be five to ten times more expensive than identical products made in the same facilities. “For many years, the World has wondered why Prescription Drugs and Pharmaceuticals in the United States were SO MUCH HIGHER IN PRICE,” he lamented.
The president pointed a finger at drug companies, who he claims have long blamed research and development costs for inflated prices, all while American consumers were saddled with these expenses alone. He made it clear: campaign contributions won’t sway him or the Republican Party. Instead, he’s positioning this order as a victory over what he calls pharmaceutical corruption.
“This is something that the Democrats have fought for many years,” he stated, emphasizing his intent to enact significant change. Scheduled for 9:00 A.M. on Monday, Trump highlighted this order as one of the most important of his presidency. The specifics of the executive order remain to be seen, but he insists it promises immediate relief.
“In the future, drug prices around the world may increase,” the president noted, “but this order will finally bring FAIRNESS TO AMERICA!” His proposal includes a policy he dubs the “Most Favored Nation’s Policy,” suggesting that Americans will pay no more than those in the country with the lowest drug prices globally.
Trump assured that this initiative would not just lighten the burden on American pockets, but could also lead to unprecedented savings for the nation as well, claiming, “the United States will save TRILLIONS OF DOLLARS.” This ambitious strategy could be a game-changer in making healthcare more affordable for millions of Americans.
As the nation anticipates the signing ceremony, many will be watching closely; the potential impact could be both significant and wide-reaching. Will this measure bring about the promised change, or will it face challenges as it heads into realities of implementation? Only time will tell, but for now, it seems healthcare costs are top of mind for the administration.
Original Source: www.foxnews.com
